Evidence map›Paper›PMID 40543023›Full record

ArticleEpilepsia2025

Automatic detection of hippocampal sclerosis in patients with epilepsy.

Marcus Belke, Felix Zahnert, Mirja Steinbrenner, Mustafa Halimeh, Gadi Miron, Panagiota-Eleni Tsalouchidou, Louise Linka, Boris Keil, Andreas Jansen, Vincent Möschl and 5 more

Abstract read
In one paragraph

Article in Epilepsia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. AI in epilepsy neuroimaging.Current opinion in neurology · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marcus BelkeDepartment of Neurology, Epilepsy Center Hessen, Philipps Universität Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0001-5131-1579
Felix ZahnertDepartment of Neurology, Epilepsy Center Hessen, Philipps Universität Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0003-0366-6724
Mirja SteinbrennerDepartment of Neurology with Experimental Neurology, Computational Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-5425-4709
Mustafa HalimehDepartment of Neurology with Experimental Neurology, Computational Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Gadi MironDepartment of Neurology with Experimental Neurology, Computational Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-0842-1806
Panagiota-Eleni TsalouchidouDepartment of Neurology, Epilepsy Center Hessen, Philipps Universität Marburg, Marburg, Germany.
Louise LinkaDepartment of Neurology, Epilepsy Center Hessen, Philipps Universität Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0003-1711-7072
Boris KeilLandes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz (LOEWE) Research Cluster for Advanced Medical Physics in Imaging and Therapy, Technische Hochschule (TH)-Mittelhessen University of Applied Sciences, Giessen, Germany.ORCID https://orcid.org/0000-0003-0805-8330
Andreas JansenCenter for Brain, Mind, and Behavior, Philipps Universität Marburg, Marburg, Germany.
Vincent MöschlDepartment of Neuropathology, Philipps Universität Marburg, Marburg, Germany.
André KemmlingDepartment of Neuroradiology, Philipps Universität Marburg, Marburg, Germany.
Christopher NimskyLandes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz (LOEWE) Research Cluster for Advanced Medical Physics in Imaging and Therapy, Technische Hochschule (TH)-Mittelhessen University of Applied Sciences, Giessen, Germany.
Felix RosenowCenter for Personalized Translational Epilepsy Research, Goethe Universität Frankfurt, Frankfurt am Main, Germany.
Katja MenzlerDepartment of Neurology, Epilepsy Center Hessen, Philipps Universität Marburg, Marburg, Germany.
Susanne KnakeDepartment of Neurology, Epilepsy Center Hessen, Philipps Universität Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0002-6298-0513

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study was undertaken to develop and validate an automatic, artificial intelligence-enhanced software tool for hippocampal sclerosis (HS) detection, using a variety of standard magnetic resonance imaging (MRI) protocols from different MRI scanners for routine clinical practice.

methodsFirst, MRI scans of 36 epilepsy patients with unilateral HS and 36 control patients with epilepsy of other etiologies were analyzed. MRI features, including hippocampal subfield volumes from three-dimensional (3D) magnetization-prepared rapid acquisition gradient echo (MPRAGE) scans and fluid-attenuated inversion recovery (FLAIR) intensities, were calculated. Hippocampal subfield volumes were corrected for total brain volume and z-scored using a dataset of 256 healthy controls. Hippocampal subfield FLAIR intensities were z-scored in relation to each subject's mean cortical FLAIR signal. Additionally, left-right ratios of FLAIR intensities and volume features were obtained. Support vector classifiers were trained on the above features to predict HS presence and laterality. In a second step, the algorithm was validated using two independent, external cohorts, including 118 patients and 116 controls in sum, scanned with different MRI scanners and acquisition protocols.

resultsClassifiers demonstrated high accuracy in HS detection and lateralization, with slight variations depending on the input image availability. The best cross-validation accuracy was achieved using both 3D MPRAGE and 3D FLAIR scans (mean accuracy = 1.0, confidence interval [CI] = .939-1.0). External validation of trained classifiers in two independent cohorts yielded accuracies of .951 (CI = .902-.980) and .889 (CI = .805-.945), respectively. In both validation cohorts, the additional use of FLAIR scans led to significantly better classification performance than the use of MPRAGE data alone (p = .016 and p = .031, respectively). A further model was trained on both validation cohorts and tested on the former training cohort, providing additional evidence for good validation performance. Comparison to a previously published algorithm showed no significant difference in performance (p = 1). SIGNIFICANCE: The method presented achieves accurate automated HS detection using standard clinical MRI protocols. It is robust and flexible and requires no image processing expertise.

Indexed as

EpilepsyHippocampusMagnetic Resonance ImagingAdolescentAdultAlgorithmsArtificial IntelligenceFemaleHippocampal SclerosisHumansImage Processing, Computer-AssistedImaging, Three-DimensionalMaleMiddle AgedSclerosisYoung AdultFreeSurferhippocampal sclerosishippocampal subfield segmentationmachine learningMRI

Identifiers

PMID40543023
PMCPMC12605791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.